Literature DB >> 10512064

Warfarin-acetaminophen drug interaction revisited.

K L Shek1, L N Chan, E Nutescu.   

Abstract

Physicians and pharmacists routinely advise patients receiving warfarin to take acetaminophen for pain or fever because of its relative safety; however, a recent study questioned the safety of such practice. A comprehensive search of MEDLINE and IPA for human studies and case reports from 1966-1999 revealed evidence that acetaminophen may potentiate the effect of warfarin by a mechanism that has yet to be elucidated. Due to lack of a safer alternative, acetaminophen still should be the analgesic and antipyretic of choice in patients taking warfarin, as long as excessive amounts and prolonged administration (> 1.3 g acetaminophen/day for > 2 wks) are avoided. With the high degree of interpatient variability and the unpredictability of various drug-drug interactions with warfarin, close and frequent monitoring of international normalized ratios is the key for safe oral anticoagulation therapy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512064     DOI: 10.1592/phco.19.15.1153.30584

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  6 in total

1.  Concomitant drug, dietary, and lifestyle issues in patients with atrial fibrillation receiving anticoagulation therapy for stroke prophylaxis.

Authors:  Edith A Nutescu; Cathy M Helgason
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

2.  The potential interaction between oral anticoagulants and acetaminophen in everyday practice.

Authors:  P M L A van den Bemt; L M Geven; N A Kuitert; A Risselada; J R B J Brouwers
Journal:  Pharm World Sci       Date:  2002-10

Review 3.  Does paracetamol potentiate the effects of oral anticoagulants?: a literature review.

Authors:  Isabelle Mahé; Charles Caulin; Jean-François Bergmann
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Association of genetic polymorphisms with warfarin dose requirements in Chinese patients.

Authors:  Yundan Liang; Zhiyu Chen; Gang Guo; Xuemei Dong; Chunting Wu; He Li; Tong Wang; Bingying Xu
Journal:  Genet Test Mol Biomarkers       Date:  2013-08-13

5.  Comparative evaluation of warfarin utilisation in two primary healthcare clinics in the Cape Town area.

Authors:  Xolani W Njovane; Pius S Fasinu; Bernd Rosenkranz
Journal:  Cardiovasc J Afr       Date:  2013-03       Impact factor: 1.167

6.  Acute warfarin toxicity: An unanticipated consequence of amoxicillin/clavulanate administration.

Authors:  Timothy R Larsen; Alehegn Gelaye; Christopher Durando
Journal:  Am J Case Rep       Date:  2014-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.